[go: up one dir, main page]

AR130477A1 - Antagonistas de c5ar1 y sus usos - Google Patents

Antagonistas de c5ar1 y sus usos

Info

Publication number
AR130477A1
AR130477A1 ARP230102436A ARP230102436A AR130477A1 AR 130477 A1 AR130477 A1 AR 130477A1 AR P230102436 A ARP230102436 A AR P230102436A AR P230102436 A ARP230102436 A AR P230102436A AR 130477 A1 AR130477 A1 AR 130477A1
Authority
AR
Argentina
Prior art keywords
c5ar1
compounds
antagonists
receptor
antagonize
Prior art date
Application number
ARP230102436A
Other languages
English (en)
Inventor
Kevin Hunt
Jianbin Zheng
sida Shen
Original Assignee
Vanqua Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanqua Bio Inc filed Critical Vanqua Bio Inc
Publication of AR130477A1 publication Critical patent/AR130477A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente memoria se proporcionan compuestos que modulan (por ejemplo, antagonizan) el receptor para el componente 5a del complemento 1 (C5aR1), un receptor acoplado a la proteína G para C5a que se asocia con trastornos autoinmunitarios, inflamatorios y neurodegenerativos. Además, se proporcionan composiciones farmacéuticas y kits que comprenden los compuestos y los métodos para tratar enfermedades y trastornos relacionados con el C5aR1 con los compuestos en un sujeto, mediante la administración de los compuestos y/o las composiciones que se describen en la presente memoria. Un compuesto con la fórmula (1).
ARP230102436A 2022-09-14 2023-09-13 Antagonistas de c5ar1 y sus usos AR130477A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263406501P 2022-09-14 2022-09-14

Publications (1)

Publication Number Publication Date
AR130477A1 true AR130477A1 (es) 2024-12-11

Family

ID=90275968

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230102436A AR130477A1 (es) 2022-09-14 2023-09-13 Antagonistas de c5ar1 y sus usos

Country Status (4)

Country Link
EP (1) EP4587014A2 (es)
AR (1) AR130477A1 (es)
TW (1) TW202425978A (es)
WO (1) WO2024059096A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025176748A1 (en) * 2024-02-22 2025-08-28 F. Hoffmann-La Roche Ag Condensed pyrazines or pyrimidines als trem2 agoonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1357111T3 (da) * 2000-12-28 2009-11-02 Shionogi & Co 2-pyridonderivater med affinitet for cannabinoid type 2-receptor
KR20180026774A (ko) * 2015-07-17 2018-03-13 후지필름 가부시키가이샤 질소-함유 헤테로시클릭 화합물
CN113924296B (zh) * 2019-05-31 2024-09-17 株式会社钟根堂 作为组蛋白脱乙酰酶6抑制剂的1,3,4-噁二唑衍生化合物及包含其的药物组合物

Also Published As

Publication number Publication date
TW202425978A (zh) 2024-07-01
WO2024059096A2 (en) 2024-03-21
WO2024059096A3 (en) 2024-04-25
EP4587014A2 (en) 2025-07-23

Similar Documents

Publication Publication Date Title
UY40204A (es) Inhibidores del Factor B del Complemento y Usos de los mismos
DOP2021000019A (es) Inhibidores de inflamasoma nlrp3
ECSP21080740A (es) Inhibidores del inflamasoma nlrp3
ECSP21027049A (es) Inhibidores de la proteína tirosina fosfatasa
UY39527A (es) Composiciones de los inhibidores de peptidos del receptor de interleucina-23
DOP2023000125A (es) Compuestos farmacéuticos
CO2019007409A2 (es) Derivados de la pirimidin enona tricíclica para la inhibición de rorγ y otros usos
CL2017002799A1 (es) Sulfonas triciclicas como moduladores del receptor huérfano relacionado con retinoide gamma (rory)
AR123685A1 (es) Antagonistas del mrgx2
CL2022001741A1 (es) Compuestos cíclicos y métodos de uso de estos
ECSP21013035A (es) Compuestos de sulfonamida sustituidos con heteroarilo y su uso como agentes terapéuticos
AR127470A1 (es) Inhibidores de lrrk2
AR133953A1 (es) Inhibidores del factor b del complemento y usos de los mismos
ECSP20079861A (es) Compuestos de bencenosulfonamida y su uso como agentes terapéuticos
AR130477A1 (es) Antagonistas de c5ar1 y sus usos
CO2018007436A2 (es) Compuestos de dihidroquinolinsulfonamida de alquilo
CO2021000229A2 (es) Compuestos de pirazol e imidazol para la inhibición de il-17 y rorgamma
CL2025000161A1 (es) Compuestos cíclicos y métodos de utilización de estos.
MX2023011377A (es) Derivados de ciclobutilo 1,3-sustituidos y sus usos.
CL2021003534A1 (es) Profármacos de moduladores del receptor de nmda.
CO2024003953A2 (es) Derivados de benzodiazepina como moduladores alostéricos positivos del receptor de gaba a gamma1
CL2025003186A1 (es) Moduladores de nk3 y usos de los mismos.
ECSP22003596A (es) Moduladores del receptor de nmda
AR133582A1 (es) Heterociclos bicíclicos como antagonistas de mrgprx2
ECSP24032316A (es) Derivados de amina bicíclicos como moduladores de receptor gabaa alfa 5